ARTICLE | Management Tracks
Civetta picks Roberts as CEO
Plus, management moves at Crinetics, OraSure, Silence, Avacta, Oncternal and more
September 3, 2021 2:34 AM UTC
Christopher Roberts became CEO at Deerfield-backed Civetta Therapeutics LLC, which is developing therapies targeting β-propeller proteins. Roberts was CSO at Black Diamond Therapeutics Inc. (NASDAQ:BDTX), before which he was entrepreneur-in-residence at SR One.
Jeff Knight joined endocrine disease company Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) as COO. Knight was SVP of portfolio management, alliance management and corporate operations at Poseida Therapeutics Inc. (NASDAQ:PSTX)...